JP Morgan Chase & Co’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $431K | Sell |
|
|||||
|
2025
Q2 | $2.33M | Sell |
|
|||||
|
2025
Q1 | $2.14M | Sell |
|
|||||
|
2024
Q4 | $2.95M | Buy |
|
|||||
|
2024
Q3 | $2.97M | Buy |
|
|||||
|
2024
Q2 | $254K | Buy |
|
|||||
|
2024
Q1 | $571K | Buy |
|
|||||
|
2023
Q4 | $570K | Sell |
|
|||||
|
2023
Q3 | $4.86M | Buy |
|
|||||
|
2023
Q2 | $184K | Buy |
|
|||||
|
2023
Q1 | $62K | Buy |
|
|||||
|
2022
Q4 | $55K | Sell |
|
|||||
|
2022
Q3 | $131K | Buy |
|
|||||
|
2022
Q2 | $122K | Sell |
|
|||||
|
2022
Q1 | $191K | Buy |
|
|||||
|
2021
Q4 | $136K | Buy |
|
|||||
|
2021
Q3 | $86K | Sell |
|
|||||
|
2021
Q2 | $281K | Buy |
|
|||||
|
2021
Q1 | $1K | Buy |
|
|||||
|
2020
Q4 | $0 | Sell |
|
|||||
|
2020
Q3 | $0 | Buy |
|
|||||
|
2020
Q2 | $0 | Sell |
|
|||||
|
2020
Q1 | $84K | Buy |
|
|||||
|
2019
Q4 | $31K | Buy |
|
|||||
|
2019
Q3 | $37K | Buy |
|
|||||
|
2019
Q2 | $28K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $513K | Sell |
|
|||||
|
2018
Q2 | $781K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $37K | Buy |
|
|||||
|
2017
Q1 | $25K | Sell |
|
|||||
|
2016
Q4 | $31K | Buy |
|